ID   Lipo815
AC   CVCL_4U87
DR   Wikidata; Q54902569
RX   PubMed=21060307;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 8
//
RX   PubMed=21060307; DOI=10.1038/labinvest.2010.185; PMCID=PMC3058694;
RA   Peng, Ting-Sheng
RA   Zhang, Ping-Yu
RA   Liu, Jeffrey Jue-Hui
RA   Nguyen, Theresa
RA   Bolshakov, Svetlana V.
RA   Belousov, Roman
RA   Young, Eric D.
RA   Wang, Xiao-Ke
RA   Brewer, Kari
RA   Lopez-Terrada, Dolores H.
RA   Oliveira, Andre M.
RA   Lazar, Alexander J.F.
RA   Lev, Dina Chelouche
RT   "An experimental model for the study of well-differentiated and
RT   dedifferentiated liposarcoma; deregulation of targetable tyrosine
RT   kinase receptors.";
RL   Lab. Invest. 91:392-403(2011).
//